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Syringomyelia and Craniocervical Junction Abnormalities in
Chihuahuas
A.-M. Kiviranta , C. Rusbridge, O. Laitinen-Vapaavuori, A. Hielm-Bj€orkman, A.K. Lappalainen,
S.P. Knowler, and T.S. Jokinen
Background: Chiari-like malformation (CM) and syringomyelia (SM) are widely reported in Cavalier King Charles Spa-
niels and Griﬀon Bruxellois dogs. Increasing evidence indicates that CM and SM also occur in other small and toy breed
dogs, such as Chihuahuas.
Objectives: To describe the presence of SM and craniocervical junction (CCJ) abnormalities in Chihuahuas and to evalu-
ate the possible association of CCJ abnormalities with SM. To describe CM/SM-related clinical signs and neurologic deﬁcits
and to investigate the association of CM/SM-related clinical signs with signalment, SM, or CCJ abnormalities.
Animals: Fifty-three client-owned Chihuahuas.
Methods: Prospective study. Questionnaire analyses and physical and neurologic examinations were obtained before mag-
netic resonance and computed tomography imaging. Images were evaluated for the presence of SM, CM, and atlantooccipital
overlapping. Additionally, medullary kinking, dorsal spinal cord compression, and their sum indices were calculated.
Results: Scratching was the most common CM/SM-related clinical sign and decreased postural reaction the most common
neurologic deﬁcit in 73 and 87% of dogs, respectively. Chiari-like malformation and SM were present in 100 and 38% of
dogs, respectively. Syringomyelia was associated with the presence of CM/SM-related clinical signs (P = 0.034), and medul-
lary kinking and sum indices were higher in dogs with clinical signs (P = 0.016 and P = 0.007, respectively).
Conclusions and Clinical Importance: Syringomyelia and CCJ abnormalities are prevalent in Chihuahuas. Syringomyelia
was an important factor for the presence of CM/SM-related clinical signs, but many dogs suﬀered from similar clinical signs
without being aﬀected by SM, highlighting the clinical importance of CCJ abnormalities in Chihuahuas.
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Chiari-like malformation (CM) and syringomyelia(SM) are widely reported in Cavalier King Charles
Spaniels (CKCSs) and Griﬀon Bruxellois dogs.1–5
Increasing evidence indicates that CM and SM also
occur in other small and toy breed dogs (e.g, Yorkshire
terriers, Chihuahuas, Maltese dogs, Pugs, Miniature
poodles, and Pomeranians).6,7
Chiari-like malformation has been deﬁned as a multi-
factorial condition that includes shortening of the entire
basicranium, loss of convexity of the supraoccipital
bone, invagination of the cerebellum under the occipital
lobes, and increased proximity of the atlas to the occi-
put, causing overcrowding of the caudal cranial fossa
and craniocervical junction (CCJ). As a compensatory
change, height of the rostral cranial cavity increases and
the dorsal cranial vault lengthens.8 Syringomyelia is
characterized by ﬂuid-ﬁlled cavities within the spinal
cord.9,10
Morphometric studies suggest that SM-aﬀected dogs
have a smaller caudal cranial fossa and relative caudal
cranial fossa overcrowding, although other studies have
challenged these results.11–17 It has further been sug-
gested that cranial venous outﬂow is impaired in SM-
aﬀected dogs, which might also contribute to the patho-
genesis of SM.18,19 Furthermore, CKCSs with SM have
a shortened and broader skull, and as a consequence,
rostrocaudal doming of the cranium.20 Similar ﬁndings
have been described in Griﬀon Bruxellois dogs.8
Recently, in addition to CM, other CCJ abnormali-
ties, such as dorsal spinal cord compression at the ﬁrst
2 cervical vertebrae, caudal position of the obex, and
atlantooccipital overlapping, have been reported to be
associated with SM.21–23
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Abbreviations:
CCJ craniocervical junction
CKCS Cavalier King Charles Spaniel
CM0 Chiari-like malformation grade 0
CM1 Chiari-like malformation grade 1
CM2 Chiari-like malformation grade 2
CM Chiari-like malformation
CT computed tomography
MRI magnetic resonance imaging
SM0 syringomyelia grade 0
SM1 syringomyelia grade 1
SM2 syringomyelia grade 2
SM syringomyelia
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Although not all SM-aﬀected dogs show clinical
signs, SM is an important predisposing factor for the
presence of neuropathic pain in dogs.1,2,24 In humans,
type I Chiari malformation, a human counterpart of
CM in dogs, also is associated with neuropathic pain,
and it has been proposed that CM alone could also
cause neuropathic pain in dogs.1,2,25 Additionally, some
evidence suggests that atlantooccipital overlapping,
medullary elevation, and dorsal spinal cord compression
are associated with clinical signs in dogs.21–23
The aims of our prospective study were to:
1 Describe the presence of SM and CCJ abnormali-
ties, including CM, dorsal spinal cord compression,
medullary elevation, and atlantooccipital overlap-
ping, in Chihuahuas.
2 Evaluate the possible association of CCJ abnormali-
ties with the presence of SM.
3 Describe the distribution of CM/SM-related clinical
signs and neurologic deﬁcits.
4 Investigate the association of CM/SM-related clini-
cal signs with SM or CCJ abnormalities in Chi-
huahuas.
5 Investigate possible associations between signalment
and presence of CM/SM-related clinical signs or
SM.
Our hypothesis was that SM and CCJ abnormalities
exist commonly in Chihuahuas and that CCJ abnormal-
ities predispose to SM. Additionally, we hypothesized
that the clinical signs and neurologic deﬁcits are compa-
rable to those previously described in CKCSs and Grif-
fon Bruxellois dogs and are associated with both SM
and CCJ abnormalities. Furthermore, we hypothesized
that no diﬀerences in sex, breed, or weight of dogs with
or without CM/SM-related clinical signs or SM will be
detected. To the authors’ knowledge, no previous
prospective studies described CM and SM imaging ﬁnd-
ings and their associations with CM/SM-related clinical
signs in Chihuahuas.
Materials and Methods
Case Selection
Client-owned Chihuahuas with or without typical clinical signs
related to CM and SM9,26 were enrolled in this prospective study,
which was approved by the Finnish National Animal Experiment
Board. Participation was voluntary and all owners provided writ-
ten consent. Recruitment of dogs was done by selecting dogs from
the case load of the Veterinary Teaching Hospital of the Univer-
sity of Helsinki. Additionally, a low-cost screening examination to
detect CM and SM in Chihuahuas was advertised at Finnish Chi-
huahua breed club events and on their website from January 2012
until August 2015.
The presence or absence of CM/SM-related clinical signs was
evaluated by an owner questionnaire designed for the study. The
CM/SM-related clinical signs used as inclusion criteria were chosen
based on previous publications.26–28 Typical CM/SM-related clini-
cal signs that we enquired about in the questionnaire included the
presence of persistent scratching episodes (ears, shoulders, or cra-
nial thoracic spine) with or without skin contact, facial rubbing,
spinal pain, vocalization, and gait abnormalities such as incoordi-
nation or weakness. If they had at least 1 of the above-mentioned
CM/SM-related clinical signs, dogs were included in the group of
dogs with CM/SM-related clinical signs.
Dogs were excluded from both groups if they had a history of
another structural central nervous system disease or a severe
orthopedic problem. Additionally, if during the study severe imag-
ing artifacts or other neurologic diseases able to cause clinical
signs similar to CM or SM were detected, dogs were excluded
from the study. No age limits were set for dogs with CM/SM-
related clinical signs, whereas dogs without CM/SM-related clini-
cal signs needed to be at least 3 years old because of the increasing
prevalence of SM until the age of 3 years in CKCSs.4
Assessment of Clinical Signs and Neurologic
Examination and Further Case Selection
Clinical and neurologic examinations were performed on all
dogs at the Veterinary Teaching Hospital, University of Helsinki,
by 1 of the authors (AMK). A detailed history was obtained for
each dog, conﬁrming the information from the owner question-
naire. If the dog had dermatologic, orthopedic, or other health
problems considered to aﬀect the CM/SM-related clinical signs,
such as scratching or abnormal gait, the dog was excluded from
the assessment of CM/SM-related clinical signs and their associa-
tion with imaging ﬁndings.
A grading system was developed for the description of the
severity of CM/SM-related clinical signs assessed by the owner
questionnaire. The presence and frequency of such CM/SM-related
clinical signs such as:
1 persistent scratching episodes of the ears or shoulders with or
without skin contact
2 persistent scratching episodes of the cranial thoracic spine
with or without skin contact
3 facial rubbing
4 spinal hyperesthesia
5 vocalization
6 gait incoordination
7 weakness
were graded from 1 (occurring <2 times a week) to 5 (occurring
several times a day). A percentage from the maximum points
(7*5 = 35 points) was calculated for each patient.
Diagnostic Imaging Analysis
All dogs underwent magnetic resonance imaging (MRI) and
computed tomography (CT) imaging of the brain and cervical
spine under general anesthesia. The anesthesia protocol was
planned individually for each patient by the anesthesiologist in
charge.
The MRI was performed with a 0.2 Tesla MR scanner.a All
dogs were positioned in sternal recumbency and with the base of
the skull aligned perpendicular to the ventral vertebral canal at the
ﬁrst 2 cervical vertebrae. In dogs without CM/SM-related clinical
signs, sagittal T1- and T2-weighted sequences of the brain and cer-
vical spine, T1- and T2-weighted transverse sequences of the brain,
and T1-weighted transverse sequences of the spinal cord between
C1 and C4/5 were acquired. In dogs with CM/SM-related clinical
signs, similar images were acquired, but additionally, the entire
cervical spinal cord was imaged and T2-weighted transverse images
of the cervical spine were obtained to eliminate other diseases,
such as intervertebral disk disease, that could cause similar clinical
signs to those of CM or SM. If considered necessary, additional
sequences, such as T1-weighted dorsal, and contrast-enhanced
(gadoteric acidb IV) transverse, and dorsal sequences of the brain
and transverse sequences of the spinal cord, were obtained to elim-
inate other diseases such as neoplasia causing secondary SM. In
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dogs with CM/SM-related clinical signs, the extent of the images
occasionally was extended based on the clinical judgment of the
neurologist (e.g, due to spinal pain located caudally to the cervical
spine, SM extending to the caudal border of the MR images). The
MRI parameters used are described in Table 1.
Computed tomographic images of the head and cranial cervical
spine, including the C3 vertebra, were acquired with a helical dual
slice scannerc with a bone algorithm. Slice thickness was 1.0 mm,
feed/rotation 2 mm, and reconstruction increment 0.5 mm. The
dogs were positioned so that the base of the skull was aligned per-
pendicular to the ventral vertebral canal in the cranial cervical
spine.
The MRI images were independently evaluated by 2 board-cer-
tiﬁed neurologists (CR and TSJ) who were blinded to the signal-
ment, CM/SM-related clinical signs, and each other’s ﬁndings. The
presence of CM and SM was graded according to the British
Veterinary Association/Kennel Club CM and SM Health Scheme:
with SM0 denoting a normal spinal cord, SM1 a central canal
dilatation or a separate syrinx with <2 mm in diameter or a presy-
rinx alone, and SM2 a central canal dilatation or a separate syrinx
with at least 2 mm in diameter (Table 2). Chiari-like malformation
was assessed from the T1- and T2-weighted sagittal images, and
SM from the T1-weighted transverse images. Additionally, if SM2
was present, each evaluator recorded the maximum syrinx width
from the T1-weighted transverse images, and the mean width of
these 2 recordings was used.
To eliminate possible middle ear diseases causing scratching or
facial rubbing, content in the tympanic bullae was evaluated as
being present or absent in the left, right, or both ears.
To provide an objective assessment of the severity of the neural
parenchymal deviation at the craniocervicomedullary junction, the
dorsal spinal cord compression caused by atlantoaxial bands and
medullary elevation caused by the dens were evaluated in MRI by
calculating the dorsal spinal cord compression index and the
medullary kinking index as previously described.29 Each dog was
measured 3 times by 1 investigator (AMK), and the mean values
of the 3 measurements were used for statistical purposes. Addi-
tionally, to evaluate the eﬀect of both dorsal and ventral compres-
sion occurring simultaneously, a sum index (dorsal spinal cord
compression index + medullary kinking index) was calculated for
each dog to assess the simultaneous eﬀect of possible bidirectional
deviation (Fig 1).
A veterinary radiologist (AKL) evaluated the CT images for the
presence of atlantooccipital overlapping. They were evaluated at
the midsagittal plane by drawing a line extending from the cau-
dodistal aspect of the supraoccipital bone to the caudal tip of the
basioccipital bone. The CCJ was considered as overlapped when
the dorsocranial border of the lamina of the atlas was at the level
of the line (grade 1) or cranial to it (grade 2). The CCJ was con-
sidered normal when the dorsocranial border of the lamina of the
atlas was caudal to the line (Fig 2A, B, and C).
Statistical Analysis
Statistical analysis was performed by a commercial software
package.d Normality of the variables was evaluated by the Kol-
mogorov-Smirnov test, and then, the appropriate parametric or
nonparametric test was used accordingly.
In all dogs eligible for the analysis of CM/SM-related clinical
signs, the association between the presence of CM/SM-related
clinical signs and signalment as well as imaging ﬁndings was evalu-
ated. The pairwise associations between the presence of CM/SM-
related clinical signs (yes/no) and each independent variable,
including breed (shorthaired or longhaired), sex, weight, presence
of SM2, atlantooccipital overlapping, and content in tympanic bul-
lae (present/absent), CM grade (CM0, CM1, CM2), and the con-
tinuous variables of age, weight, medullary kinking index, dorsal
spinal cord compression index, and sum index were studied with
univariable logistic regression analysis by the method “enter” with
only 1 independent variable in the model at a time. For statistical
Table 1. MRI parameters used for imaging the head
and cervical spine.
Sequence and
plain obtained Anatomy imaged TR (ms) TE (ms)
T1W sagittal Brain and cervical
spine
420–790 18
T2W sagittal Brain and cervical
spine
2,500–3,000 80
T1W transverse Brain 600–1190 18
T2W transverse Brain 2,500–4,870 80
T1W transverse Cervical spinal cord 490–1110 18
T2W transverse Spinal cord 2,500–3,770 80
T1 dorsal Head 490–600 18
TR, time of repetition; TE, time of echo. The slice thickness
was 3.5–4.5 mm and the matrix 256 9 256.
Table 2. Grading of Chiari-like malformation and syr-
ingomyelia according to the British Veterinary Associa-
tion/Kennel Club Chiari-like malformation and
Syringomyelia health scheme.
Chiari-like malformation
CM0 No Chiari-like malformation
CM1 Cerebellum indented (not rounded)
CM2 Cerebellum impacted, or herniated through the
foramen magnum
Syringomyelia
SM0 Normal, no central canal dilatation, no syrinx, no
presyrinx
SM1 Central canal dilatation or a separate syrinx with
<2 mm diameter, or a presyrinx alone
SM2 Central canal dilatation or a separate syrinx with at
least 2 mm diameter measured at maximal width in
a transverse plane
CM, Chiari-like malformation; SM, syringomyelia.
Fig 1. T2-weighted midsagittal magnetic resonance image of a
Chihuahua dog with concurrent medullary elevation and dorsal
spinal cord compression of the spinal cord at C1-2 cervical verte-
brae. The lower arrow indicates the medullary elevation and the
upper arrow the dorsal spinal cord compression.
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purposes, dogs were considered as having content in the tympanic
bullae if there was content in either or both ears. In cases with dif-
ferent results in estimated categorical variables, a consensus deci-
sion was reached by the evaluators. For statistical purposes, SM2
was considered to be either present or absent; hence, the dogs with
SM2 were compared with both dogs with and without central
canal dilatation (SM0 + SM1).
Additionally, a correlation between the severity of CM/SM-
related clinical signs (a percentage from maximum points based on
owner questionnaire) and the width of the syrinx (when SM2 was
present), the medullary kinking index, and the sum index were
assessed by Pearson correlation.
Before evaluating the relationship between the presence of CM/
SM-related clinical signs and imaging ﬁndings with multivariable
logistic regression analysis, Spearman correlation for the nonpara-
metric variables and Pearson correlation for the parametric vari-
ables were evaluated.
A multivariable logistic regression was used to model the associ-
ation of the presence of CM/SM-related clinical signs and col-
lected signalment and imaging analysis variables by the forward
likelihood ratio method. For the multivariable regression analysis,
variables with Wald’s P < 0.2 were included.
For the variables in the ﬁnal model, the area under the receiver
operator characteristic (ROC) curve (AUC) was calculated to esti-
mate the optimal cut-oﬀ point to detect dogs with or without CM/
SM-related clinical signs.
Similarly, associations between SM2 and signalment, presence
of CM/SM-related clinical signs, neurologic deﬁcits, and imaging
ﬁndings (other than SM2) were evaluated. The pairwise associa-
tions between the presence of SM2 (yes/no) and each independent
variable, including breed, sex, presence of CM/SM-related clinical
signs (yes/no), postural reaction deﬁcits (yes/no), abnormal gait
(yes/no), content in tympanic bullae (yes/no), atlantooccipital
overlapping (yes/no), and CM grade (CM0, CM1, CM2), and the
continuous variables of age, weight, medullary kinking index, dor-
sal spinal cord compression index, and sum index were studied by
univariable logistic regression analysis.
Finally, a multivariable logistic regression was used to model
the association between SM2 and collected variables similar to
that described for the presence of CM/SM-related clinical signs.
The goodness of ﬁt of the multivariable logistic regression ﬁnal
models was assessed with the Omnibus test of model coeﬃcients,
Nagelkerke’s R2, and the Hosmer-Lemeshow test. The smaller the
P-value in the Omnibus test, the larger the value in the Hosmer-
Lemeshow test and the closer the value to 100% in Nagelkerke’s
R2, the better the ﬁt (i.e, the better the model is able to predict
correctly the dogs with CM/SM-related clinical signs or the pres-
ence of SM). In all cases, signiﬁcance was set at P < 0.05.
Results
Animals
Altogether, 65 Chihuahuas were examined, but 12
dogs were excluded for various reasons (Fig 3). The
remaining 53 dogs comprised 26 (49%) longhaired and
26 (49%) smooth-haired Chihuahuas and 1 (2%) Chi-
huahua mix (smooth haired). Twenty-seven dogs (51%)
were females, 25 dogs (47%) were males, and 1 dog
(2%) was a neutered male (classiﬁed as a male in statis-
tical analysis). The mean  SD age of the dogs at study
entry was 57  27 months (range, 7–139 months), and
the mean  SD weight was 2.8  0.7 kg (range, 1.4–
4.3 kg).
A
B
C
Fig 2. (A, B, and C) Classiﬁcation of atlantooccipital overlap-
ping. The craniocervical junction was considered normal when the
dorsocranial border of the lamina of the atlas was caudal to the
purple line (A). The craniocervical junction was considered as
overlapped when the dorsocranial border of the lamina of the
atlas was at the level of the purple line extending from the
caudodistal aspect of the supraoccipital bone to the caudal tip of
the basioccipital bone (grade 1, B) or cranial to it (grade 2, C).
The blue line in the images is an indicator line produced by the
DICOM viewer. [Color ﬁgure can be viewed at wileyonlinelibrar-
y.com]
1774 Kiviranta et al
Assessment of Clinical Signs and Neurologic Deficits
Of the 53 included dogs, 9 were excluded from the
assessment of clinical signs because of various health
problems, but were included in the description of neuro-
logic deﬁcits and in imaging analyses (Fig 3). This was
done because previous or concurrent non-neurologic
Figure 2
Neurologic examination: n= 53
Imaging analysis:
Magnetic resonance imaging (n= 53) and computed
tomography (n=50, three dogs lacking CT images)
Description of CM/SM-related clinical signs and association
with the imaging findings: n= 44
9 dogs excluded due to:
• chronic gastrointestinal disease (4/9)
• unilateral patellar luxation (2/9)
• dermatological disease (3/9), in one dog
also dental disease
Diseases not considered to affect the
imaging analysis or neurologic examination
Chihuahuas recruited: n= 65
8 dogs with CM/SM-related clinical signs excluded
due to:
• microchip artifact causing undiagnostic
MR  images (1/8)
• intervertebral disc disease (3/8)
• severe supracollicular fluid accumulation
(2/8), additional severe hydrocephalus in
one dog
• history of corticosteroid-responsive neck
pain (1/8)
• bilateral patellar luxation (1/8)
4 dogs without CM/SM-related clinical signs
excluded due to:
• too young (2/4)
• acute nonambulatory paraparesis 11 days
after imaging due to necropsy-confirmed
granulomatous meningoencepalomyelitis
(1/4)
• history of corticosteroid-responsive
meningoencephalomyelitis of unknown
origin (1/4)
Fig 3. Flowchart describing the inclusion/exclusion of Chihuahuas in imaging analysis, description of neurological deﬁcits, and CM/SM-
related clinical signs.
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diseases might cause diﬃculties in interpreting the origin
and severity of CM/SM-related clinical signs, but were
not considered to interfere with the neurologic examina-
tion or imaging ﬁndings.
Of the remaining 44 dogs, 22 of 44 (50%) had and 22
of 44 dogs did not have CM/SM-related clinical signs.
Mean age (P = 0.271), weight (P = 0.154), and sex dis-
tribution (P = 0.073) did not diﬀer between the 2
groups (Table 3a and b).
In all, 16 of 22 dogs (73%) with CM/SM-related clinical
signs had been scratching their ears, shoulders, or cranial
thoracic area with or without skin contact. Facial rubbing
and head or spinal hyperesthesia were both reported in 10
of 22 dogs (46%). Vocalization when scratching, excited, or
moving occurred in 9/22 dogs (41%), and in 12 of 22 dogs
(55%) the owners reported occasional incoordination, stum-
bling, or weakness in either thoracic or pelvic limbs or both.
Eighteen (82%) of the 22 dogs had multiple CM/SM-
related clinical signs. Four owners (18%) of the 22 dogs
reported their dogs to have only 1 CM/SM-related clini-
cal sign, and in 3 of 4 dogs, it was scratching.
The mean  SD onset of CM/SM-related clinical
signs was 15.4  19 months (range, 3–84 months), and
scratching was the most common ﬁrst CM/SM-related
clinical sign noted in 12 of 20 dogs (60%). (Two owners
did not deﬁne the onset of clinical signs.)
Neurologic deﬁcits were detected in 31 of 53 dogs
(59%). A detailed description of the deﬁcits detected in
all dogs is provided in Table 4. Neurologic deﬁcits were
observed in 21 of 22 dogs (96%) with CM/SM-related
clinical signs and in 1 of 22 dogs (5%) without CM/
SM-related clinical signs. The most common deﬁcits
were decreased postural reactions in 20 of 22 dogs
(91%) and ataxia in 12 of 22 dogs (55%).
Table 3. (a) Association of signalment and imaging ﬁndings with CM/SM-related clinical signs (nonparametric vari-
ables), (b) the presence CM/SM-related clinical signs (parametric variables).
Variable
Number of Dogs with
CM/SM-Related Clinical Signs (%)
Number of Dogs without
CM/SM-Related Clinical Signs (%)
Number of
Dogs/All Dogs P
(a)
Smooth haired 11 (25%) 9 (20%) 20/44 0.545
Longhaired 11 (25%) 13 (30%) 24/44
Sex: M 13 (30%) 7 (16%) 20/44 0.073
Sex: F 9 (20%) 15 (34%) 24/44
CM0 0 (0%) 0 (0%) 0/44 0.111
CM1 1 (2%) 5 (11%) 6/44
CM2 21 (48%) 17 (39%) 38/44
No SM2 (SM0 + SM1) 10 (23%) 17 (39%) 27/44 0.034*
SM2 12 (27%) 5 (11%) 17/44
No bulla tympanica content 17 (39%) 20 (45%) 37/44 0.230
Bulla tympanica content 5 (11%) 2 (5%) 7/44
No AOO 5 (12%) 6 (14%) 11/43 0.795
AOO 16 (37%) 16 (37%) 32/43
Variable
Dogs with CM/SM-Related
Clinical Signs (mean)
SD (with CM/SM-Related
Clinical Signs)
Dogs without
CM/SM-Related
Clinical Signs (mean)
SD (no CM/SM-Related
Clinical Signs) P
(b)
Age (months) 53.9 35.5 63.3 17.6 0.271
Weight (kg) 2.7 0.7 2.9 0.6 0.154
MKI 26.9% 7.4 19.8% 8.4% 0.016*
DSCCI 25.8% 7.1 23.8% 7.5% 0.370
SI 53.0% 8.7 44.2% 8.9 0.007*
CM/SM, Chiari-like malformation and/or syringomyelia; M, male; F, female; CM0, no Chiari-like malformation; CM1, cerebellar indenta-
tion; CM2, cerebellar herniation or impaction into the foramen magnum; SM2, syringomyelia (syrinx width at least 2 mm in transverse plane);
AOO, atlantooccipital overlapping; SD, standard deviation; MKI, Medullary kinking index; DSCCI, dorsal spinal cord compression index;
SI, sum index (MKI + DSCCI). Variables with a P-value <0.2 are bolded and ones with a P-value <0.05 are indicated with an asterisk.
Table 4. Neurologic deﬁcits detected in 31 of 53 Chihuahuas examined.
Deﬁcit Detected Number of Dogs
Proportion of
Dogs with Neurologic
Deﬁcits (%)
Proportion of
All Dogs
Examined (%)
Decreased postural reactions 27 87 51
Abnormal gait (mild to moderate hypermetria in front/hindlimbs or both) 18 58 34
Decreased or absent menace (uni- or bilateral) 15 48 28
Spinal hyperesthesia 12 39 23
Abnormal posture (kyphosis, holding head down) 8 26 15
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Diagnostic Imaging Analysis
Chiari-like malformation was observed in all 53 dogs:
cerebellar indentation in 11 of 53 dogs (21%) and cere-
bellar herniation in 42 of 53 dogs (79%). Central canal
dilatation was detected in 15 of 53 dogs (28%) and SM
in 20 of 53 dogs (38%). In 18 of 53 dogs (40%), no SM
or central canal dilatation was detected.
The medullary kinking index could be measured in 50
of 53 dogs, and the mean  SD was 23.2  8.5%
(range, 6.1–48.0%). The dorsal spinal cord compression
index was measured in all 53 dogs, and mean  SD
was 24.3  7.3% (range, 8.7–37.5%). The sum index
was measured in 50 of 53 dogs, and the mean  SD
was 47.8  9.8% (range, 29.2–69.6%).
Content in tympanic bullae was present in 8 of 53
dogs (15%) either unilaterally (4 of 53 [7.5%] dogs) or
bilaterally (4 of 53 [7.5%] dogs).
Computed tomography imaging ﬁndings were avail-
able for 50/53 dogs. In 15 of 50 dogs (30%), the atlas
was positioned caudal to the foramen magnum, but in
35 of 50 dogs (70%) atlantooccipital overlapping was
considered present: grade 1 in 23 of 50 dogs (46%) and
grade 2 in 12 of 50 dogs (24.0%). The presence or
severity of atlantooccipital overlapping was not associ-
ated with the severity of CM (P = 0.145).
Association between the Presence and Severity of
Clinical Signs and Diagnostic Imaging Findings
The presence of SM2 was associated with the pres-
ence of CM/SM-related clinical signs (P = 0.034). Addi-
tionally, CM/SM-related clinical signs were more severe
in SM-aﬀected dogs than in dogs without SM2 (21.3%
from maximum points in SM2-aﬀected dogs and 9.1%
in nonaﬀected dogs, P = 0.041). When SM2 was pre-
sent, the mean maximum syrinx width was 3.8 mm in
dogs with CM/SM-related clinical signs and 3.2 mm in
dogs without CM/SM-related clinical signs, but the dif-
ference was not signiﬁcant (P = 0.490).
Ten (45%) of the 22 dogs with CM/SM-related clini-
cal signs did not have SM2 at the cervical spine. Six of
these 10 dogs suﬀered from scratching (4/6 scratching
their head or shoulder area), 6 of 10 dogs had facial
rubbing, 4 of 10 dogs had pain on spinal palpation, 5
of 10 dogs had spontaneous vocalization, and 2 of 10
dogs had occasional incoordination, stumbling, or
weakness.
The mean medullary kinking and sum indices were
signiﬁcantly higher (P = 0.016 and P = 0.007, respec-
tively) in dogs with CM/SM-related clinical signs than
in dogs without CM/SM-related clinical signs. Further-
more, the sum index correlated positively with the
severity of CM/SM-related clinical signs (P = 0.025),
although the medullary kinking index alone did not
(P = 0.092). A detailed description of the variables
analyzed is presented in Table 3a and b. With a cut-
oﬀ value of 0.46 for the sum index, the model had a
sensitivity of 0.90 and a speciﬁcity of 0.67, and the
AUC was 0.76 (95% conﬁdence interval [CI] 0.61–
0.91).
Before evaluating the relationship between the pres-
ence of CM/SM-related clinical signs and imaging ﬁnd-
ings with multivariable logistic regression analysis,
correlations of the selected variables (sex, CM grade,
presence of SM2, weight, medullary kinking, and sum
indices) were evaluated: sex and weight (P = 0.002) and
medullary kinking and sum indices (P = <0.001) corre-
lated with each other. Due to the correlation between
medullary kinking and sum indices, only the sum index
was selected because of its lower p-value (see Table 3b).
In the multivariable logistic regression analysis, only
the sum index remained in the ﬁnal model (P = 0.007),
and it was signiﬁcantly predictive for the presence of
clinical signs. The goodness of ﬁt of this ﬁnal model
was conﬁrmed by an Omnibus value of 0.002 and a
Hosmer-Lemeshow value of 0.079. The model could
correctly predict 65.9% of the data and explain 27.4%
of the variance according to the pseudo-R2 test
(Nagelkerke).
Association of Signalment, Neurologic Deficits, and
Imaging Findings with the Presence of Syringomyelia
In addition to the presence of CM/SM-related clinical
signs, postural reaction deﬁcits (P < 0.001) were
associated with the presence of SM2. A detailed descrip-
tion of the factors evaluated is provided in Table 5a, b,
and c.
Before evaluating the relationship between the pres-
ence of SM2 and CM/SM-related clinical signs, neuro-
logic deﬁcits, and imaging ﬁndings with multivariable
logistic regression analysis, correlations of the selected
variables (presence of CM/SM-related clinical signs,
presence of postural reaction deﬁcits, presence of gait
abnormalities, CM grade, and sum index) were evalu-
ated. Multiple correlations were detected between the
presence of CM/SM-related clinical signs and postural
reaction deﬁcits (P < 0.001), abnormal gait (P < 0.001),
and sum index (P = 0.003). Additionally, the presence
of postural reaction deﬁcits and sum index was corre-
lated (P = 0.024). Finally, there also was a correlation
between abnormal gait and postural reaction deﬁcits
(P = 0.005). Because of multicollinearity, a forward
stepping method was used.
In multivariable logistic regression analysis, only 1
variable remained in the ﬁnal model: the presence of
postural reaction deﬁcits was signiﬁcantly predictive for
SM2 (P = 0.002). The goodness of ﬁt of this second
ﬁnal model was conﬁrmed by an Omnibus value of
0.001. The model could correctly predict 75.6% of the
data and explain 33% of the variance according to the
pseudo-R2 test (Nagelkerke).
Discussion
We found that SM, CM, and several other CCJ abnor-
malities are commonly encountered in Chihuahuas. The
CM/SM-related clinical signs in Chihuahuas are compa-
rable with those detected in SM-aﬀected CKCSs. Inter-
estingly, CM/SM-related clinical signs also are
commonly present in dogs without SM and may be
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attributed to CCJ abnormalities. These CCJ abnormali-
ties, including medullary elevation and dorsal spinal cord
compression, especially if present concurrently and caus-
ing a bidirectional compression of the medulla or spinal
cord, may play an important role in the pathogenesis of
SM and neuropathic pain in Chihuahuas.
CM/SM-Related Clinical Signs and Neurologic
Deficits
The most common clinical sign noted was scratching
of the ears, shoulders, or cranial thoracic area with or
without skin contact, seen in approximately 70% of
dogs. Also, approximately half of the dogs rubbed
their face, vocalized, or had spinal cord hyperesthesia
indicative of neuropathic pain. In half of the dogs, the
owners had noticed that their dog’s gait was abnormal.
Previous studies report comparable percentages of sim-
ilar clinical signs in CM/SM-aﬀected CKCSs: scratch-
ing and dysesthetic behavior, including phantom
scratching or facial rubbing, was detected in 25% (3 of
12 dogs) to 100% (7 of 7 dogs) of clinically aﬀected
dogs, cervical hyperesthesia in 58–71% (5 of 7 and 7
of 12 dogs), and abnormal gait in 25–43% (3 of 7 and
3 of 12 dogs).26,28 Unfortunately, studies describing
clinical signs in detail are limited and include a low
number of cases.
Occasionally, before ﬁlling out the questionnaire,
owners had been unaware that repeated scratching,
although present for months or years, could be a sign
of disease. Commonly, the reason for veterinary consul-
tation was some other complaint (e.g, avoidance of
touch, epileptic seizures). This ﬁnding highlights the
need to educate breeders and dog owners in recognizing
milder signs so that neuropathic pain caused by CM or
SM can be alleviated. Prospective studies with detailed
questionnaires are needed to make the published
research more reliable by avoiding dogs with CM/SM-
related clinical signs being falsely included in the group
of dogs without CM/SM-related clinical signs.
Table 5. (a) Association of signalment and neurologic examination ﬁndings with syringomyelia, (b) Association of
imaging ﬁndings with syringomyelia, (c) Association of signalment and imaging ﬁndings with syringomyelia (para-
metric variables).
(a)
Variable Dogs with SM (%) Dogs without SM (%) Number of Dogs/All Dogs P
Smooth haired 12 (23%) 15 (28%) 27/53 0.307
Longhaired 8 (15%) 18 (34%) 26/53
Sex: M 11 (21%) 15 (28%) 26/53 0.501
Sex: F 9 (17%) 18 (34%) 27/53
CM/SM-related clinical signs 12 (27%) 10 (23%) 22/44 0.034*
No CM/SM-related clinical signs 5 (11%) 17 (39%) 22/44
Postural reaction deﬁcits 16 (30%) 10 (19%) 26/53 0.001*
No postural reaction deﬁcits 4 (8%) 23 (43%) 27/53
Abnormal gait 9 (17%) 8 (15%) 17/53 0.121
Normal gait 11 (21%) 25 (47%) 36/53
(b)
Variable – Imaging Findings Dogs with SM (%) Dogs without SM (%) Number of Dogs/All Dogs P
CM0 0 (0%) 0 (0%) 0/53 0.148
CM1 2 (4%) 9 (17%) 11/53
CM2 18 (34%) 24 (45%) 42/53
Bulla tympanica content 4 (8%) 4 (8%) 8/53 0.441
No bulla tympanica content 16 (30%) 29 (55%) 45/53
AOO 15 (30%) 20 (40%) 35/50 0.530
No AOO 5 (10%) 10 (20%) 15/35
(c)
Variable – Signalment Dogs with SM (mean) SD (with SM) Dogs without SM (mean) SD (no SM) P
Age (months) 61.8 31.6 54.1 23.7 0.319
Weight (kg) 2.7 0.7 2.8 0.6 0.418
Variable – Imaging ﬁndings Dogs with SM (mean) SD (with SM) Dogs without SM (mean) SD (no SM) P
MKI 24.2% 7.0 22.6% 9.3 0.519
DSCCI 25.8% 7.1 23.4% 7.3 0.223
SI 50.5% 8.7 46.3% 10.1 0.146
M, male; F, female; CM/SM, Chiari-like malformation and/or syringomyelia; SM, syringomyelia, CM0, no Chiari-like malformation;
CM1, cerebellar indentation; CM2, cerebellar herniation or impaction into the foramen magnum; AOO, atlantooccipital overlapping; SM,
syringomyelia (syrinx width at least 2 mm in transverse plane); SD, standard deviation; MKI, Medullary kinking index; DSCCI, dorsal spinal
cord compression index; SI, sum index. Variables with a P-value <0.2 are bolded and ones with a P-value <0.05 are indicated with an asterisk.
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Neurologic deﬁcits were similar to those previously
described in CKCSs and Griﬀon Bruxellois dogs,5,26
with the most common neurologic deﬁcits being postu-
ral reaction deﬁcits and ataxia in all but 1 (21/22) of
the dogs with CM/SM-related clinical signs.
Diagnostic Imaging Findings and their Associations
with CM/SM-Related Clinical Signs
Chiari-like Malformation and Syringomyelia
All dogs in our study had CM. This ﬁnding is similar
to previous studies, with occurrence of CM in nonran-
domized CKCS study populations varying between 94
and 100%, but higher than the 60.7–80% reported in
Griﬀon Bruxellois dogs.3,5,8,11,12,21
Syringomyelia was detected in dogs with and without
CM/SM-related clinical signs, as also reported earlier.1 Of
dogs without CM/SM-related clinical signs, 23% had SM,
which is less than previously reported in CKCSs (46%)
and Griﬀon Bruxellois dogs (46–52%).3–5,8 However,
because the prevalence of SM might increase with age and
because the selection of dogs was based on voluntary par-
ticipation of the owners (and hence not randomized), the
prevalence of imaging ﬁndings might not reﬂect the true
prevalence in a randomly selected population.
Syringomyelia was associated with the presence of
CM/SM-related clinical signs, consistent with earlier
research. Previous studies also suggest an association
between the presence of neuropathic pain and increased
syrinx width.1,2 In our study, the mean syrinx width
was higher in dogs with CM/SM-related clinical signs,
but the diﬀerence was not signiﬁcant. This ﬁnding
might be due to a proportionally higher number (45%)
of dogs with CM/SM-related clinical signs but without
SM than in a previous study (13%) of CKCSs.2
Dorsal Spinal cord Compression and Medullary
Elevation
Dorsal spinal cord compression and medullary eleva-
tion previously have been associated with the presence
of CM/SM-related clinical signs in CKCSs over 5 years
of age.21,22 In our study, the medullary kinking index
was signiﬁcantly higher in dogs with than without CM/
SM-related clinical signs, but no statistical diﬀerence
was detected in dorsal spinal cord compression index
between the 2 groups. The diﬀerence between the results
of these 2 studies might be due to our choice of measur-
ing the dorsal spinal cord compression index in all dogs
to avoid bias caused by initially subjectively assessing
the presence of dorsal spinal cord compression, and
then if compression was present, calculating the dorsal
spinal cord compression index.
Despite no statistical diﬀerence in dorsal spinal cord
compression index being recognized between dogs with
and without CM/SM-related clinical signs, the cranial
cervical spinal cord at the atlantoaxial junction com-
monly seemed strongly deviated and had an S-shaped
appearance due to the concurrent medullary elevation
and dorsal spinal cord compression (Fig 1). To study the
eﬀect of bidirectional compression deviating the spinal
cord, the sum index (medullary kinking index + dorsal
spinal cord compression index) was evaluated. The sum
index was signiﬁcantly higher in dogs with than without
CM/SM-related clinical signs, and it was predictive of the
presence of CM/SM-related clinical signs in multivariable
logistic regression analysis. Additionally, it correlated
positively with the severity of CM/SM-related clinical
signs, whereas medullary kinking index or dorsal spinal
cord compression index alone did not.
The CM/SM-related clinical signs, such as scratching
and facial rubbing, also were detected in half of the
dogs without SM at the cervical spine. In previous
reports, medullary elevation was suggested to cause
neuropathic pain, but the presence of multiple CCJ
junction abnormalities and the high percentage of SM-
aﬀected dogs render estimation of causality problem-
atic.22 The high number of dogs without SM but with
CM/SM-related clinical signs suggestive of neuropathic
pain detected in our study supports the clinical impor-
tance of concurrent CCJ abnormalities, such as CM,
medullary elevation, and dorsal spinal cord compres-
sion, in the pathogenesis of neuropathic pain, and these
clinical signs are similar to those observed in dogs with
only CM.10 The exact pathomechanism and anatomical
structures responsible for the clinical signs caused by
these CCJ abnormalities remain to be elucidated. Com-
pression of the spinal nucleus and tract of cranial nerve
V, continuing as the substantia gelatinosa and dorsolat-
eral fasciculus in the spinal cord and receiving sensory
input related to nociception and temperature from the
skin and mucous membranes of the head, might be at
least partly responsible.30
Atlantooccipital Overlapping
Atlantooccipital overlapping was detected in 70% of
dogs evaluated in our study, but it was not associated
with the presence of CM/SM-related clinical signs,
SM, or severity of CM. In previous studies, a subjec-
tive assessment of the presence of atlantooccipital
overlapping based on 3-dimensional reconstructed CT
images has been used. The studies report atlantooccipi-
tal overlapping to be present in 27.7% of small and
toy breed dogs, and more speciﬁcally, in 55.2% of
non-CKCS dogs.29 Recently, a study with criteria
resembling ours reported a prevalence of atlantooccipi-
tal overlapping of 80% in dogs imaged with MRI.23
The only exception in the criteria was that in our
study dogs with an atlas immediately caudal to the
foramen magnum were not considered to be aﬀected
by atlantooccipital overlap. To avoid bias caused by
the subjective assessment of the cranial tip of the atlas
being “immediately caudal” to the foramen magnum,
we considered dogs to be aﬀected when the cranial tip
of the atlas was at the caudal border of the foramen
magnum (on a line drawn from dorsocaudal to ventro-
caudal borders of the foramen magnum). This diﬀer-
ence in the criteria for the presence of atlantooccipital
overlapping might underestimate the number of dogs
aﬀected in our study or overestimate the number in
the other study.
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Previously, atlantooccipital overlapping has been
reported to be associated with the presence of CM
and SM, but not with the presence of CM/SM-related
clinical signs.23 The diﬀerence in the diagnostic criteria
of atlantooccipital overlapping, the diﬀerence in the
imaging method used, and the ubiquitous presence of
CM in our study might explain why we were unable
to show an association between atlantooccipital over-
lapping and CM or SM. Additionally, we used the
British Veterinary Association/Kennel Club CM and
SM Health Scheme classiﬁcation for the presence of
SM (Table 2). The dogs were considered to be SM-
aﬀected if the maximum width of the lesion was at
least 2 mm, which diﬀers from the criterion used in
previous studies (i.e, SM present when lesion >1 mm
in width).2,21
Limitations of the Study
Our study had some limitations. At the time of
study entry, 9/22 dogs with CM/SM-related clinical
signs were already medicated, which might have inﬂu-
enced the presence and severity of clinical signs, caus-
ing an underestimation of the severity of clinical signs.
Additionally, 9/53 dogs had to be excluded from the
evaluation of CM/SM-related clinical signs because of
concurrent non-neurological diseases, such as dermato-
logic diseases, which could have aﬀected the evalua-
tion of clinical signs. These 9 dogs were still included
in the imaging analyses. There were 8/53 dogs (15%)
with either uni- or bilateral content in tympanic bul-
lae. Despite this, they were included in the clinical
analyses because the presence of content was not asso-
ciated with the presence of clinical signs in statistical
analysis.
All dogs in our study underwent low-ﬁeld MRI.
Because of the very small size of patients and the low
magnetic ﬁeld strength, it was occasionally diﬃcult to
diﬀerentiate a mildly dilated central canal from imaging
artifacts. This might have caused underestimation of the
number of dogs with central canal dilatation.
Conclusions
We have described for the ﬁrst time the presence of
SM, CM, and other CCJ abnormalities and their associ-
ations with clinical signs previously considered to be
caused by CM or SM in Chihuahuas. The presence of
CM was ubiquitous, and both SM and CCJ abnormali-
ties occurred commonly. The clinical signs considered
as CM/SM-related clinical signs in our study were simi-
lar to those reported previously in other breeds.
Although SM was an important factor for the presence
of these clinical signs, many dogs suﬀered from similar
clinical signs without being aﬀected by SM. Indices
measuring medullary elevation alone or in combination
with dorsal spinal cord compression were signiﬁcantly
higher in dogs with CM/SM-related clinical signs. These
ﬁndings highlight the importance of CCJ abnormalities
other than CM in the pathogenesis of neuropathic pain
in Chihuahuas.
Footnotes
a Esaote S.p.A, Genova, Italy
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